Literature DB >> 11120394

Drug addiction, dysregulation of reward, and allostasis.

G F Koob1, M Le Moal.   

Abstract

This paper reviews recent developments in the neurocircuitry and neurobiology of addiction from a perspective of allostasis. A model is proposed for brain changes that occur during the development of addiction that explain the persistent vulnerability to relapse long after drug-taking has ceased. Addiction is presented as a cycle of spiralling dysregulation of brain reward systems that progressively increases, resulting in the compulsive use and loss of control over drug-taking. The development of addiction recruits different sources of reinforcement, different neuroadaptive mechanisms, and different neurochemical changes to dysregulate the brain reward system. Counteradaptive processes such as opponent-process that are part of normal homeostatic limitation of reward function fail to return within the normal homeostatic range and are hypothesized to form an allostatic state. Allostasis from the addiction perspective is defined as the process of maintaining apparent reward function stability by changes in brain reward mechanisms. The allostatic state represents a chronic deviation of reward set point and is fueled not only by dysregulation of reward circuits per se, but also by the activation of brain and hormonal stress responses. The manifestation of this allostatic state as compulsive drug-taking and loss of control over drug-taking is hypothesized to be expressed through activation of brain circuits involved in compulsive behavior such as the cortico-striatal-thalamic loop. The view that addiction is the pathology that results from an allostatic mechanism using the circuits established for natural rewards provides a realistic approach to identifying the neurobiological factors that produce vulnerability to addiction and relapse.

Entities:  

Mesh:

Year:  2001        PMID: 11120394     DOI: 10.1016/S0893-133X(00)00195-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  913 in total

Review 1.  The neuroscience of natural rewards: relevance to addictive drugs.

Authors:  Ann E Kelley; Kent C Berridge
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.

Authors:  R Andrew Chambers; David W Self
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

3.  Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference.

Authors:  A González-Cuello; L Mora; J M Hidalgo; N Meca; C Lasheras; M V Milanés; M L Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-06       Impact factor: 3.000

4.  The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system.

Authors:  Heather N Lavezzi; Daniel S Zahm
Journal:  Basal Ganglia       Date:  2011-11

Review 5.  Arousal and drug abuse.

Authors:  Francisco J Urbano; Verónica Bisagno; Edgar Garcia-Rill
Journal:  Behav Brain Res       Date:  2017-07-17       Impact factor: 3.332

6.  Social status predicts response to dietary cycling in female rhesus monkeys.

Authors:  Kaitlyn M Roman; Mark E Wilson; Vasiliki Michopoulos
Journal:  Appetite       Date:  2018-07-19       Impact factor: 3.868

7.  Shared genetic factors influence risk for bipolar disorder and alcohol use disorders.

Authors:  N Carmiol; J M Peralta; L Almasy; J Contreras; A Pacheco; M A Escamilla; E E M Knowles; H Raventós; D C Glahn
Journal:  Eur Psychiatry       Date:  2013-12-08       Impact factor: 5.361

8.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

9.  The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.

Authors:  Jonathan Henry W Jacobsen; Femke T A Buisman-Pijlman; Sanam Mustafa; Kenner C Rice; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 7.217

Review 10.  Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.

Authors:  Rebecca J Houston; Nicolas J Schlienz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.